Real-World Evidence on Low-Dose Olanzapine (≤1.25 mg) for Personalized Antipsychotic Dosing.

J Pers Med · 2025 · PMC12387202 · PMID 40863442

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The hazard ratios for cardiovascular disease (HR = 0.88, 95% CI: 0.51–1.49) and cerebrovascular events (HR = 0.75, 95% CI: 0.41–1.36) also favored the low-dose group but did not reach statistical significance, likely due to the limited number of events ( Table 3 ). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.